The SWIFT Model for Lichen Sclerosus Among Premenarchal Girls.


Journal

Journal of lower genital tract disease
ISSN: 1526-0976
Titre abrégé: J Low Genit Tract Dis
Pays: United States
ID NLM: 9704963

Informations de publication

Date de publication:
01 Jan 2022
Historique:
entrez: 20 12 2021
pubmed: 21 12 2021
medline: 24 12 2021
Statut: ppublish

Résumé

Delay in diagnosis of childhood lichen sclerosus (LS) can be ameliorated with an efficient evaluation tool. We sought to create a useful prognostic tool for rapid and accurate risk stratification for LS in premenarchal girls. We conducted a retrospective chart review at a single institution of premenarchal girls presenting with vulvovaginal complaints at a specialty pediatric and adolescent gynecology clinic at a major academic center. Sixty-nine patients seen between July 2019 and September 2020 were used as a pilot study to create a model for LS based on 18 signs and symptoms. Accuracy of the pilot model was confirmed in a larger data set (additional 105 patients, seen between January 2017 and December 2020), and model parameters were refined through cluster-based analytics. Pilot study yielded 5 predictors for LS: soreness (S), whitening (W), urinary incontinence (I), fissures (F), and thickening of the clitoral hood (T)-SWIFT. The final refined model is given as log odds (LS) = -7 + 3·S + 17·W + 3·I + 3·F + 18·T. This model yielded a >97% accuracy in predicting LS among 174 unique patients (LS prevalence = 18%). The SWIFT model accurately predicts clinical diagnosis of LS in premenarchal girls. Replication in other patient populations is highly encouraged. Awareness of LS is paramount, and an efficient, accurate evaluation tool will prove invaluable in assuring timely diagnosis and treatment for premenarchal patients.

Identifiants

pubmed: 34928252
doi: 10.1097/LGT.0000000000000634
pii: 00128360-202201000-00010
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

46-52

Informations de copyright

Copyright © 2021, ASCCP.

Déclaration de conflit d'intérêts

The authors have declared they have no conflicts of interest.

Références

Dendrinos ML, Quint EH. Lichen sclerosus in children and adolescents. Curr Opin Obstet Gynecol 2013;25:370–4.
Powell J, Wojnarowska F. Childhood vulvar lichen sclerosus: an increasingly common problem. J Am Acad Dermatol 2001;44:803–6.
Lagerstedt M, Karvinen K, Joki-Erkkilä M, et al. Childhood lichen sclerosus—a challenge for clinicians. Pediatr Dermatol 2013;30:444–50.
Wang M, Arlen AM, Vash-Margita A. Characteristics among premenarchal girls with lichen sclerosus. J Low Genit Tract Dis 2021;25:152–7.
Bercaw-Pratt JL, Boardman LA, Simms-Cendan JS; North American Society for Pediatric and Adolescent Gynecology. Clinical recommendation: pediatric lichen sclerosus. J Pediatr Adolesc Gynecol 2014;27:111–6.
Smith SD, Fischer G. Childhood onset vulvar lichen sclerosus does not resolve at puberty: a prospective case series. Pediatr Dermatol 2009;26:725–9.
Morrel B, van Eersel R, Burger CW, et al. The long-term clinical consequences of juvenile vulvar lichen sclerosus: a systematic review. J Am Acad Dermatol 2020;82:469–77.
Cooper S, Gao XH, Powell J, et al. Does treatment of vulvar lichen sclerosus influence its prognosis? Arch Dermatol 2004;140:702–6.
Jensen LS, Bygum A. Childhood lichen sclerosus is a rare but important diagnosis. Dan Med J 2012;59:A4424.
Fistarol SK, Itin PH. Diagnosis and treatment of lichen sclerosus: an update. Am J Clin Dermatol 2013;14:27–47.
Simpson RC, Cooper SM, Kirtschig G, et al. Future research priorities for lichen sclerosus—results of a James Lind Alliance Priority Setting Partnership. Br J Dermatol 2019;180:1236–7.
von Gontard A. The impact of DSM-5 and guidelines for assessment and treatment of elimination disorders. Eur Child Adolesc Psychiatry 2013;22(suppl 1):S61–7.
Rutter M. Multiaxial Classification of Child and Adolescent Psychiatric Disorders: The ICD-10 Classification of Mental and Behavioural Disorders in Children and Adolescents . Cambridge: Cambridge University Press; 1996.
Lewis FM, Tatnall FM, Velangi SS, et al. British Association of Dermatologists guidelines for the management of lichen sclerosus, 2018. Br J Dermatol 2018;178:839–53.
Berth-Jones J, Graham-Brown RA, Burns DA. Lichen sclerosus et atrophicus—a review of 15 cases in young girls. Clin Exp Dermatol 1991;16:14–7.
Dinh H, Purcell SM, Chung C, et al. Pediatric lichen sclerosus: a review of the literature and management recommendations. J Clin Aesthet Dermatol 2016;9:49–54.
Ismail D, Owen CM. Paediatric vulval lichen sclerosus: a retrospective study. Clin Exp Dermatol 2019;44:753–8.
Nerantzoulis I, Grigoriadis T, Michala L. Genital lichen sclerosus in childhood and adolescence—a retrospective case series of 15 patients: early diagnosis is crucial to avoid long-term sequelae. Eur J Pediatr 2017;176:1429–32.
Owen CM, Yell JA. Genital lichen sclerosus associated with incontinence. J Obstet Gynaecol 2002;22:209–10.
Austin PF, Bauer SB, Bower W, et al. The standardization of terminology of lower urinary tract function in children and adolescents: update report from the standardization committee of the International Children's Continence Society. NeurourolUrodyn 2016;35:471–81.
Haylen BT, De Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn 2010;29:4–20.

Auteurs

Melinda Wang (M)

Division of Pediatric and Adolescent Gynecology, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, CT.

Alla Vash-Margita (A)

Division of Pediatric and Adolescent Gynecology, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, CT.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH